CASC

Cascadian Therapeutics, Inc.
CASC

Overview Fund Activity
Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

79 hedge funds and large institutions have $166M invested in Cascadian Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 8 closing their positions.

Holders
79
Holders Change
+3
Holders Change %
+3.95%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
24
Reduced
15
Closed
8
Calls
$164K
Puts
$94K
Net Calls
+$70K
Net Calls Change
+$12K

Top Buyers

1
TCM
1
Tekla Capital Management
Massachusetts
$1.86M
2
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$2.09M
3
PC
3
Polar Capital
United Kingdom
$5.11M
4
PAWC
4
P.A.W. Capital
Connecticut
$982K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$7.69M

Top Sellers

1
RG
1
Redmile Group
California
$8.06M
2
AFM
2
Anson Funds Management
Texas
$0
3
MIM
3
Monashee Investment Management
Massachusetts
$0
4
OAM
4
Oxford Asset Management
United Kingdom
$558K
5
BCM
5
Bridgeway Capital Management
Texas
$982K
Name Holding Trade Value Shares
Change 		Shares
Change %
DADC
76
D.A. Davidson & Co
Montana
– -$14K -3,833 Closed
MAM
77
Meeder Asset Management
Ohio
– -$4K -1,014 Closed
1 2 3
4